Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27042152 | 0.97 | TSHR (0.68) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL27042141 | 0.97 | TSHR (0.68) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL27042289 | 0.97 | TSHR (0.68) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL27042377 | 0.94 | TSHR (0.72) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL15215970 | 0.93 | TSHR (0.62) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL3816946 | 0.93 | CYP3A4 (0.73) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL1295773 | 0.93 | CYP3A4 (0.73) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL3816327 | 0.91 | CYP3A4 (0.70) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL1260434 | 0.91 | CYP3A4 (0.70) | TSHRCYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL22844591 | 0.91 | CYP3A4 (0.70) | TSHRCYP3A4LPAR3LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | claimed |
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | disclosed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-3313918-B1 | HIGHLY TRANSPARENT COATED CELLULOSETRIACETATE FILM | ISLAND POLYMER IND GMBH (DE) | 2022-05-25 | — | — | EP | disclosed |
| EP-3262107-B1 | MULTIFUNCTIONAL OPTICAL HIGHLY TRANSPARENT FILMS AND METHOD FOR PRODUCING THE SAME | ISLAND POLYMER IND GMBH (DE) | 2021-12-22 | — | — | EP | disclosed |
| US-10988590-B2 | Highly transparent coated cellulose triacetate film and dissolver medium | ISLAND POLYMER INDUSTRIES GMBH (DE) | 2021-04-27 | — | — | US | disclosed |
| US-10865302-B2 | Resin composition and use thereof | ZEON CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-20190040249-A1 | RESIN COMPOSITION AND USE THEREOF | ZEON CORPORATION (JP) | 2019-02-07 | — | — | US | disclosed |
| US-20180194913-A1 | HIGHLY TRANSPARENT COATED CELLULOSE TRIACETATE FILM AND DISSOLVER MEDIUM | ISLAND POLYMER INDUSTRIES GMBH (DE) | 2018-07-12 | — | — | US | disclosed |
| EP-3313918-A1 | HIGH-TRANSPARENCY COATED CELLULOSE TRIACETATE FILM AND DISSOLVER MEDIUM | Island Polymer Industries GmbH (DE) | 2018-05-02 | — | — | EP | disclosed |
| US-20070222920-A1 | POLARIZER PROTECTIVE FILM, POLARIZING PLATE AND VA MODE LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070218218-A1 | Cellulose acylate optical film, producing method thereof, polarizing plate and liquid crystal display using the same | KONICA MINOLTA OPTO, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070128380-A1 | Cellulose Ester Film, Its Manufacturing Method, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070092663-A1 | Cellulose ester film, polarizing plate and display | KONICA MINOLTA OPTO, INC. | 2007-04-26 | — | — | US | disclosed |
| US-20070046870-A1 | Liquid crystal display device | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20070046872-A1 | Liquid crystal display | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20060292315-A1 | Polarizing plate and display device | KONICA MINOLTA OPTO, INC (JP) | 2006-12-28 | — | — | US | disclosed |
| US-20060280882-A1 | Cellulose ester film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2006-12-14 | — | — | US | disclosed |
| US-20060127607-A1 | Plasticizer, cellulose ester film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | ACHE, BCHE, MUSK | TSHR 708/4885CYP3A4 1005/4885LPAR3 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.